ArticleBMC ophthalmology2026
Type I to type II Boston keratoprosthesis exchange: a report of two patients.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo report two cases of Boston Keratoprosthesis (BKPro) type I failure in patients with severe ocular surface disease and to describe the successful replacement of the BKPro type 1 with a BKPro type II, highlighting clinical indications, surgical considerations, and postoperative outcomes. This is a case report of two patients with a history of complex ocular surface pathology-one with Stevens-Johnson Syndrome and the other with bilateral chemical burns-both of whom had previously undergone type I BKPro implantation and subsequently developed complications including corneal melt and backplate exposure. Clinical presentation, surgical intervention, and follow-up are detailed. A literature review was conducted to identify previously reported cases and recommendations regarding type I BKPro replacement with type II BKPro. CASE PRESENTATION: Both patients underwent successful explantation of the type I BKPro and implantation of a type II BKPro in a combined procedure with pars plana vitrectomy. In one case, corneal melt around the type 1 BKPro developed in the setting of Stevens-Johnson Syndrome prompting replacement with a type 2 BKPro. In the second case, dacryoadenectomy may have contributed to ocular surface instability and corneal melt. Visual acuity improved in both cases postoperatively, with stable device positioning and no signs of infection or retinal complications at last follow-up.
conclusionsTransitioning from type I BKPro to type II is a feasible and effective strategy in patients with severe ocular surface disease and BKPro failure due to corneal melt in the setting of history of Stevens Johnson Syndrome and chemical injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.